Who Makes Zofran (ondansetron): Manufacturer Overview

Zofran is manufactured by Novartis, a multinational pharmaceutical corporation based in Basel, Switzerland. Zofran (ondansetron) was developed by GlaxoSmithKline in London in the mid-1980s but sold the rights to Zofran and and its oncology medications to Novartis in 2015.

Zofran Manufacturer Overview

Trade Name	Zofran
Manufacturer	Novartis (Previously GlaxoSmithKline)
Active Ingredient	Ondansetron hydrochloride (HCl)
Formula	C₁₈H₁₉N₃O
FDA-Approval Date	January 1991
FDA-Approved Uses	Prevents nausea and vomiting caused by chemotherapy, radiation, or surgery.
Website	https://www.novartis.com

What Does Zofran Treat?

Zofran is primarily used to prevent and treat nausea and vomiting caused by chemotherapy, radiation, or surgery. It works by blocking the action of serotonin, a chemical in the body that can trigger these symptoms.

Zofran is commonly used in the following situations:

Chemotherapy and radiation therapy: Zofran helps prevent nausea and vomiting caused by these cancer treatments.
Surgery: It can be used before and after surgery to reduce nausea and vomiting.
Postoperative nausea and vomiting (PONV): Zofran can be used to treat nausea and vomiting that occur after surgery.
Other situations: In some cases, Zofran may be used to treat nausea and vomiting caused by other conditions, such as migraines or motion sickness.

It is important to note that Zofran is a prescription medication and should only be taken under the supervision of a healthcare professional. They can determine if Zofran is the right treatment for your specific condition and address any potential risks or side effects.

Explore More Medication Manufacturers

Now that you know more about who makes Zofran, the manufacturer details, and what medical conditions it treats, you may want to compare Zofran to other medication manufacturers.

Browse the medication maker guides to research popular brands and find information on a specific company.